608 related articles for article (PubMed ID: 26332594)
1. Identification of Medically Actionable Secondary Findings in the 1000 Genomes.
Olfson E; Cottrell CE; Davidson NO; Gurnett CA; Heusel JW; Stitziel NO; Chen LS; Hartz S; Nagarajan R; Saccone NL; Bierut LJ
PLoS One; 2015; 10(9):e0135193. PubMed ID: 26332594
[TBL] [Abstract][Full Text] [Related]
2. Actionable, pathogenic incidental findings in 1,000 participants' exomes.
Dorschner MO; Amendola LM; Turner EH; Robertson PD; Shirts BH; Gallego CJ; Bennett RL; Jones KL; Tokita MJ; Bennett JT; Kim JH; Rosenthal EA; Kim DS; ; Tabor HK; Bamshad MJ; Motulsky AG; Scott CR; Pritchard CC; Walsh T; Burke W; Raskind WH; Byers P; Hisama FM; Nickerson DA; Jarvik GP
Am J Hum Genet; 2013 Oct; 93(4):631-40. PubMed ID: 24055113
[TBL] [Abstract][Full Text] [Related]
3. Application of ACMG criteria to classify variants in the human gene mutation database.
Qu HQ; Wang X; Tian L; Hakonarson H
J Hum Genet; 2019 Nov; 64(11):1091-1095. PubMed ID: 31451714
[TBL] [Abstract][Full Text] [Related]
4. Physician-directed genetic screening to evaluate personal risk for medically actionable disorders: a large multi-center cohort study.
Haverfield EV; Esplin ED; Aguilar SJ; Hatchell KE; Ormond KE; Hanson-Kahn A; Atwal PS; Macklin-Mantia S; Hines S; Sak CW; Tucker S; Bleyl SB; Hulick PJ; Gordon OK; Velsher L; Gu JYJ; Weissman SM; Kruisselbrink T; Abel C; Kettles M; Slavotinek A; Mendelsohn BA; Green RC; Aradhya S; Nussbaum RL
BMC Med; 2021 Aug; 19(1):199. PubMed ID: 34404389
[TBL] [Abstract][Full Text] [Related]
5. Incidentalome from Genomic Sequencing: A Barrier to Personalized Medicine?
Jamuar SS; Kuan JL; Brett M; Tiang Z; Tan WL; Lim JY; Liew WK; Javed A; Liew WK; Law HY; Tan ES; Lai A; Ng I; Teo YY; Venkatesh B; Reversade B; Tan EC; Foo R
EBioMedicine; 2016 Mar; 5():211-6. PubMed ID: 27077130
[TBL] [Abstract][Full Text] [Related]
6. The Clinical Genome and Ancestry Report: An interactive web application for prioritizing clinically implicated variants from genome sequencing data with ancestry composition.
Lee IH; Negron JA; Hernandez-Ferrer C; Alvarez WJ; Mandl KD; Kong SW
Hum Mutat; 2020 Feb; 41(2):387-396. PubMed ID: 31691385
[TBL] [Abstract][Full Text] [Related]
7. The burden of pathogenic variants in clinically actionable genes in a founder population.
Lynch MT; Maloney KA; Pollin TI; Streeten EA; Xu H; ; Shuldiner AR; Van Hout CV; Gonzaga-Jauregui C; Mitchell BD
Am J Med Genet A; 2021 Nov; 185(11):3476-3484. PubMed ID: 34467620
[TBL] [Abstract][Full Text] [Related]
8. Actionable genomic variants in 6045 participants from the Qatar Genome Program.
Elfatih A; Mifsud B; Syed N; Badii R; Mbarek H; Abbaszadeh F; ; Estivill X
Hum Mutat; 2021 Aug; ():. PubMed ID: 34428338
[TBL] [Abstract][Full Text] [Related]
9. Psychiatric manifestations of rare variation in medically actionable genes: a PheWAS approach.
Feng YA; Stanaway IB; Connolly JJ; Denny JC; Luo Y; Weng C; Wei WQ; Weiss ST; Karlson EW; Smoller JW
BMC Genomics; 2022 May; 23(1):385. PubMed ID: 35590255
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer.
Maxwell KN; Hart SN; Vijai J; Schrader KA; Slavin TP; Thomas T; Wubbenhorst B; Ravichandran V; Moore RM; Hu C; Guidugli L; Wenz B; Domchek SM; Robson ME; Szabo C; Neuhausen SL; Weitzel JN; Offit K; Couch FJ; Nathanson KL
Am J Hum Genet; 2016 May; 98(5):801-817. PubMed ID: 27153395
[TBL] [Abstract][Full Text] [Related]
11. Frequency and management of medically actionable incidental findings from genome and exome sequencing data: a systematic review.
Elfatih A; Mohammed I; Abdelrahman D; Mifsud B
Physiol Genomics; 2021 Sep; 53(9):373-384. PubMed ID: 34250816
[TBL] [Abstract][Full Text] [Related]
12. Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium.
Amendola LM; Jarvik GP; Leo MC; McLaughlin HM; Akkari Y; Amaral MD; Berg JS; Biswas S; Bowling KM; Conlin LK; Cooper GM; Dorschner MO; Dulik MC; Ghazani AA; Ghosh R; Green RC; Hart R; Horton C; Johnston JJ; Lebo MS; Milosavljevic A; Ou J; Pak CM; Patel RY; Punj S; Richards CS; Salama J; Strande NT; Yang Y; Plon SE; Biesecker LG; Rehm HL
Am J Hum Genet; 2016 Jun; 98(6):1067-1076. PubMed ID: 27181684
[TBL] [Abstract][Full Text] [Related]
13. Copy number alterations involving 59 ACMG-recommended secondary findings genes.
Yatsenko SA; Aarabi M; Hu J; Surti U; Ortiz D; Madan-Khetarpal S; Saller DN; Bellissimo D; Rajkovic A
Clin Genet; 2020 Dec; 98(6):577-588. PubMed ID: 33009833
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic and Uncertain Genetic Variants Have Clinical Cardiac Correlates in Diverse Biobank Participants.
Pottinger TD; Puckelwartz MJ; Pesce LL; Robinson A; Kearns S; Pacheco JA; Rasmussen-Torvik LJ; Smith ME; Chisholm R; McNally EM
J Am Heart Assoc; 2020 Feb; 9(3):e013808. PubMed ID: 32009526
[TBL] [Abstract][Full Text] [Related]
15. Clinical exome performance for reporting secondary genetic findings.
Park JY; Clark P; Londin E; Sponziello M; Kricka LJ; Fortina P
Clin Chem; 2015 Jan; 61(1):213-20. PubMed ID: 25414276
[TBL] [Abstract][Full Text] [Related]
16. Actionable secondary findings in the 73 ACMG-recommended genes in 1559 Thai exomes.
Chetruengchai W; Shotelersuk V
J Hum Genet; 2022 Mar; 67(3):137-142. PubMed ID: 34621001
[TBL] [Abstract][Full Text] [Related]
17. High-frequency actionable pathogenic exome variants in an average-risk cohort.
Rego S; Dagan-Rosenfeld O; Zhou W; Sailani MR; Limcaoco P; Colbert E; Avina M; Wheeler J; Craig C; Salins D; Röst HL; Dunn J; McLaughlin T; Steinmetz LM; Bernstein JA; Snyder MP
Cold Spring Harb Mol Case Stud; 2018 Dec; 4(6):. PubMed ID: 30487145
[TBL] [Abstract][Full Text] [Related]
18. Variant Classification Concordance using the ACMG-AMP Variant Interpretation Guidelines across Nine Genomic Implementation Research Studies.
Amendola LM; Muenzen K; Biesecker LG; Bowling KM; Cooper GM; Dorschner MO; Driscoll C; Foreman AKM; Golden-Grant K; Greally JM; Hindorff L; Kanavy D; Jobanputra V; Johnston JJ; Kenny EE; McNulty S; Murali P; Ou J; Powell BC; Rehm HL; Rolf B; Roman TS; Van Ziffle J; Guha S; Abhyankar A; Crosslin D; Venner E; Yuan B; Zouk H; ; Jarvik GP
Am J Hum Genet; 2020 Nov; 107(5):932-941. PubMed ID: 33108757
[TBL] [Abstract][Full Text] [Related]
19. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Richards S; Aziz N; Bale S; Bick D; Das S; Gastier-Foster J; Grody WW; Hegde M; Lyon E; Spector E; Voelkerding K; Rehm HL;
Genet Med; 2015 May; 17(5):405-24. PubMed ID: 25741868
[TBL] [Abstract][Full Text] [Related]
20. PATH-SCAN: a reporting tool for identifying clinically actionable variants.
Daneshjou R; Zappala Z; Kukurba K; Boyle SM; Ormond KE; Klein TE; Snyder M; Bustamante CD; Altman RB; Montgomery SB
Pac Symp Biocomput; 2014; ():229-40. PubMed ID: 24297550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
